A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors
Clinical trial NCT06816108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06816108
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-21
- Primary completion
- 2029-07-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.